IS PROSTATE CANCER STAGE MIGRATION CONTINUING FOR BLACK MEN IN THE PSA ERA?

被引：0
|
作者：
Dobbs, Ryan
Greenwald, David
Wadhwa, Harpreet
Freeman, Vincent
Abem, Michael
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.1760
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD42-08
引用
收藏
页码：E990 / E990
页数：1
相关论文
共 50 条
  • [21] Metastatic prostate cancer in the modern era of PSA screening
    Fontenot, Philip A., Jr.
    Nehra, Avinash
    Parker, William
    Wyre, Hadley
    Mirza, Moben
    Duchene, David A.
    Holzbeierlein, Jeffrey
    Thrasher, James Brantley
    Van Veldhuizen, Peter
    Lee, Eugene K.
    INTERNATIONAL BRAZ J UROL, 2017, 43 (03): : 416 - 421
  • [22] Percent free PSA in black and white men with histologic BPH and histologic prostate cancer.
    Kilambi, NK
    Fowler, JH
    Sanders, J
    Land, SA
    JOURNAL OF UROLOGY, 1998, 159 (05): : 234 - 234
  • [23] Continuing controversy over monitoring men with localized prostate cancer: A systematic review of programs in the prostate specific antigen era
    Martin, Richard M.
    Gunnell, David
    Hamdy, Freddie
    Neal, David
    Lane, Athene
    Donovan, Jenny
    JOURNAL OF UROLOGY, 2006, 176 (02): : 439 - 449
  • [24] Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era
    Jani, AB
    Vaida, F
    Hanks, G
    Asbell, S
    Sartor, O
    Moul, JW
    Roach, M
    Brachman, D
    Kalokhe, U
    Muller-Runkel, R
    Ray, P
    Ignacio, L
    Awan, A
    Weichselbaum, RR
    Vijayakumar, S
    INTERNATIONAL JOURNAL OF CANCER, 2001, 96 (06) : 363 - 371
  • [25] External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era
    Pollack, A
    Smith, LG
    von Eschenbach, AC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (02): : 507 - 512
  • [26] Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era
    Chen, Maxine M.
    Jahn, Jaquelyn L.
    Barber, John R.
    Han, Misop
    Stampfer, Meir J.
    Platz, Elizabeth A.
    Penney, Kathryn L.
    PLOS ONE, 2020, 15 (06):
  • [27] Prostate cancer detection among men with a low PSA
    Lavoipierre, AM
    Gong, SJ
    Frydenberg, M
    Chen, JY
    BJU INTERNATIONAL, 2005, 95 : 8 - 9
  • [28] Is PSA a poor predictor of prostate cancer in obese men?
    Banez, Lionel L.
    Aronson, William J., Jr.
    Wen, Joanne
    Wuerstle, Melanie
    Shah, Amy
    Lai, Dominic W.
    Moalej, Bita
    Atala, Christina
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 642 - 642
  • [29] Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era
    Descazeaud, Aurelien
    Peyromaure, Michael
    Salin, Ambroise
    Amsellem-Ouazana, Delphine
    Flam, Thierry
    Viellefond, Annick
    Debre, Bernard
    Zerbib, Marc
    EUROPEAN UROLOGY, 2008, 53 (02) : 355 - 362
  • [30] Predictive factors of progression in patients with clinical stage T1a prostate cancer in the psa era
    Descazeaud, A.
    Salin, A.
    Peyromaure, M.
    Flam, T.
    Vieillefond, A. Z.
    Debre, B.
    Zerbib, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 276 - 276
12345